.png){kind=icon}
.png){kind=icon}
Return
Reply to Yılmaz et al., “Caution in Interpreting Tralokinumab Outcomes in Dupilumab Nonresponders”
.png){kind=icon}
PRE
AI
V
T
DOI：10.1016/j.jaad.2026.07.120.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En
Journal
IF:
11.8
Papers:
2.6W
Citations:
3.9W
Organization
Cited Papers